Adicet Bio
ACET
ACET
100 hedge funds and large institutions have $370M invested in Adicet Bio in 2022 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 31 increasing their positions, 30 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
5.72% less ownership
Funds ownership: 103.79% → 98.07% (-5.7%)
21% less capital invested
Capital invested by funds: $467M → $370M (-$96.9M)
50% less funds holding in top 10
Funds holding in top 10: 6 → 3 (-3)
Holders
100
Holding in Top 10
3
Calls
$843K
Puts
$752K
Top Buyers
| 1 | +$31.8M | |
| 2 | +$7.18M | |
| 3 | +$6.26M | |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
+$5.36M |
| 5 |
BlackRock
New York
|
+$3.9M |
Top Sellers
| 1 | -$29.3M | |
| 2 | -$11.7M | |
| 3 | -$7.15M | |
| 4 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$7M |
| 5 |
ABG
Ally Bridge Group
New York
|
-$3.48M |